These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2553421)
1. Immunoprophylaxis of cytomegalovirus infections in transplanted patients. Bron D; Klastersky J Eur J Cancer Clin Oncol; 1989 Sep; 25(9):1365-8. PubMed ID: 2553421 [TBL] [Abstract][Full Text] [Related]
2. Issues concerning the use of intravenous immunoglobulins for the immunoprophylaxis of cytomegalovirus infections in allogeneic bone marrow transplant recipients. Emanuel D Monogr Allergy; 1988; 23():216-24. PubMed ID: 2838745 [No Abstract] [Full Text] [Related]
3. Cytomegalovirus immunoglobulins in the prevention and treatment of cytomegalovirus disease. Snydman DR Rev Infect Dis; 1990; 12 Suppl 7():S839-48. PubMed ID: 2173113 [TBL] [Abstract][Full Text] [Related]
4. [Specific anti-cytomegalovirus immunoglobulins in the prevention of cytomegalovirus infections in bone marrow allografts]. Huart JJ; Baume D; Jouet JP Ann Med Interne (Paris); 1987; 138(5):372-4. PubMed ID: 2823667 [TBL] [Abstract][Full Text] [Related]
5. Selection of an intravenous immune globulin for the immunoprophylaxis of cytomegalovirus infections: an in vitro comparison of currently available and previously effective immune globulins. Chehimi J; Peppard J; Emanuel D Bone Marrow Transplant; 1987 Dec; 2(4):395-402. PubMed ID: 2844341 [TBL] [Abstract][Full Text] [Related]
6. [Cytomegalovirus infections after kidney transplantation and passive immunization]. Wienand P; Grundmann R; Runde A; Zippel C Immun Infekt; 1985 Sep; 13(5):203-9. PubMed ID: 2998975 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of hyperimmune anti-cytomegalovirus immunoglobulins for the prevention of cytomegalovirus infection in recipients of allogeneic bone marrow transplantation: a meta-analysis. Messori A; Rampazzo R; Scroccaro G; Martini N Bone Marrow Transplant; 1994 Feb; 13(2):163-7. PubMed ID: 8205085 [TBL] [Abstract][Full Text] [Related]
8. Failure to prevent cytomegalovirus infection by cytomegalovirus hyperimmune plasma: a randomized trial by the Nordic Bone Marrow Transplantation Group. Ringdén O; Pihlstedt P; Volin L; Nikoskelainen J; Lönnqvist B; Ruutu P; Ruutu T; Toivanen A; Wahren B Bone Marrow Transplant; 1987 Oct; 2(3):299-305. PubMed ID: 2844340 [TBL] [Abstract][Full Text] [Related]
9. Anti-CMV hyperimmune globulin prophylaxis does not prevent CMV disease in CMV-negative renal transplant patients. Pakkala S; Salmela K; Lautenschlager I; Ahonen J; Häyry P Transplant Proc; 1992 Feb; 24(1):283-4. PubMed ID: 1311472 [No Abstract] [Full Text] [Related]
11. [Cytomegalovirus hyperimmune globulin prophylaxis in bone marrow transplants in children with various diseases]. Ebell W; Blütters-Sawatzki R; Friedrich W; Hampl W; Kleihauer E Immun Infekt; 1985 Nov; 13(6):307-12. PubMed ID: 3000925 [TBL] [Abstract][Full Text] [Related]
12. Prophylaxis of CMV infection in bone marrow transplant recipients by hyperimmune CMV gamma-globulin. Condie RM; O'Reilly RJ Dev Biol Stand; 1982; 52():501-13. PubMed ID: 6299859 [TBL] [Abstract][Full Text] [Related]
13. Immune globulin (GAMMAGARD) prophylaxis of CMV infections in patients undergoing organ transplantation and allogeneic bone marrow transplantation. Fehir KM; Decker WA; Samo T; Young JB; Lederer E; Lawrence EC Transplant Proc; 1989 Feb; 21(1 Pt 3):3107-9. PubMed ID: 2539691 [No Abstract] [Full Text] [Related]
14. [Clinical use of immunoglobulin titers of anti-cytomegalovirus antibodies]. Pouteil-Noble C; Touraine JL; Gibert R; Aymard M Rev Fr Transfus Immunohematol; 1984 Jun; 27(3):365-74. PubMed ID: 6091228 [TBL] [Abstract][Full Text] [Related]
15. [Clinical and biological evaluation of the preventive role of anti-cytomegalovirus specific immunoglobulins in bone marrow grafts. Randomized study of 60 patients]. Bordigoni P; Janot C; Aymard JP; Witz F; Bené MC; Legras B; Schoonemann F; Olive D; Streiff F Nouv Rev Fr Hematol (1978); 1987; 29(5):289-93. PubMed ID: 2830588 [TBL] [Abstract][Full Text] [Related]
16. Prevention of CMV infection after BMT in high-risk patients using CMV hyperimmune globulin. Einsele H; Vallbracht A; Schmidt H; Friese M; Schüch K; Haen M; Dopfer R; Niethammer D; Waller HD; Ehninger G Cancer Detect Prev; 1988; 12(1-6):637-41. PubMed ID: 2846173 [TBL] [Abstract][Full Text] [Related]